When.com Web Search

  1. Ads

    related to: immunosuppressive antibody vaccine for sale ontario buy

Search results

  1. Results From The WOW.Com Content Network
  2. Eculizumab - Wikipedia

    en.wikipedia.org/wiki/Eculizumab

    Eculizumab, sold under the brand name Soliris among others, is a recombinant humanized monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica.

  3. Immunosuppressive drug - Wikipedia

    en.wikipedia.org/wiki/Immunosuppressive_drug

    Some studies showed a low vaccination rate against some Vaccine-preventable disease among patients taking immunosuppressive drugs, despite a generally positive attitude towards vaccinations. [13] There are also other side-effects, such as hypertension, dyslipidemia, hyperglycemia, peptic ulcers, lipodystrophy, moon face, liver injury and kidney ...

  4. Nirsevimab - Wikipedia

    en.wikipedia.org/wiki/Nirsevimab

    Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). [10] [11] It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor [6] that is designed to bind to the fusion protein on the surface of the RSV virus.

  5. CimaVax-EGF - Wikipedia

    en.wikipedia.org/wiki/CimaVax-EGF

    CimaVax-EGF is a vaccine used to treat cancer, specifically non-small-cell lung carcinoma (NSCLC). CIMAvax-EGF is composed of recombinant human epidermal growth factor (EGF) conjugated to a protein carrier. [2] The vaccine was developed by the Center of Molecular Immunology, Havana, Cuba, and made available to the Cuban population in 2011.

  6. AstraZeneca buys respiratory vaccine developer Icosavax in $1 ...

    www.aol.com/news/astrazeneca-buy-rsv-vaccine...

    It set up a separate vaccine and antibody therapy division in late 2021. The upfront payment by AstraZeneca represents a premium of about 43% to Icosavax's last close. Shares in Icosavax rose 45% ...

  7. Benralizumab - Wikipedia

    en.wikipedia.org/wiki/Benralizumab

    Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor . It was developed by MedImmune for the treatment of asthma. It is currently marketed by Astrazeneca. [3] [4] Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016.